← Leaderboards
Christopher M Adams
University Of Iowa
$8,482,157
Attributed
$13,207,307
Total exposure
12
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,207,307 · 10
VA$0 · 2
By mechanism
R01$6,604,828 · 3
R44$5,992,477 · 4
R43$385,002 · 2
R41$225,000 · 1
I01$0 · 2
Top collaborators
- Scott Matthew Ebert10 shared
- John Jeffrey Talley9 shared
- Andrew Robert Judge2 shared
- Sarah M Judge2 shared
- Aleksey V Matveyenko1 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Mark Anthony Yorek$7,990,158
- Michael Dyle$40,007
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectMuscular AtrophyBaseLeadMedicalSkeletal Muscle WastingProteinsQuality Of LifeMouse ModelAtrophicFallsMuscle FibersMuscle FormMuscleSkeletal MusclePreventMalignant NeoplasmsAgingAge RelatedIndependent LivingMolecularMediator Of Activation ProteinIn VivoMuscle Function
Grant awards (38)
Development of novel therapeutics for obesity and type 2 diabetes$1,021,719
R44 · FY2025 · DK
Development of novel therapeutics for cancer cachexia$997,245
R44 · FY2024 · CA
Development of novel therapeutics for cancer cachexia$990,411
R44 · FY2023 · CA
Novel Signaling Pathways Underlying Skeletal Muscle Atrophy$512,069
R01 · FY2022 · AG · contact PI
Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy$745,404
R44 · FY2021 · AR
Novel Signaling Pathways Underlying Skeletal Muscle Atrophy$526,819
R01 · FY2021 · AG · contact PI
Molecular pathogenesis of skeletal muscle atrophy$472,103
R01 · FY2021 · AR · contact PI
Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy$745,404
R44 · FY2020 · AR
Novel signaling pathways underlying skeletal muscle atrophy$523,483
R01 · FY2020 · AG · contact PI
Molecular pathogenesis of skeletal muscle atrophy$473,936
R01 · FY2020 · AR · contact PI
Molecular Mechanisms of Age-related Muscle Loss$0
I01 · FY2020 · VA · contact PI
Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy$746,147
R44 · FY2019 · AG
Novel signaling pathways underlying skeletal muscle atrophy$523,483
R01 · FY2019 · AG · contact PI
Molecular pathogenesis of skeletal muscle atrophy$475,228
R01 · FY2019 · AR · contact PI
Molecular Mechanisms of Age-related Muscle Loss$0
I01 · FY2019 · VA · contact PI
Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy$746,147
R44 · FY2018 · AG
Novel signaling pathways underlying skeletal muscle atrophy$536,608
R01 · FY2018 · AG · contact PI
Molecular pathogenesis of skeletal muscle atrophy$477,130
R01 · FY2018 · AR · contact PI
Molecular pathogenesis of skeletal muscle atrophy$504,901
R01 · FY2017 · AR · contact PI
Prevention and Treatment of Skeletal Muscle Atrophy$0
I01 · FY2017 · VA · contact PI
Prevention and Treatment of Skeletal Muscle Atrophy$0
I01 · FY2017 · VA · contact PI
Molecular Mechanisms of Age-related Muscle Loss$0
I01 · FY2017 · VA · contact PI
Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy$225,000
R43 · FY2016 · AR
Prevention and Treatment of Skeletal Muscle Atrophy$0
I01 · FY2016 · VA · contact PI
Molecular Mechanisms of Age-related Muscle Loss$0
I01 · FY2016 · VA · contact PI
Prevention and Treatment of Skeletal Muscle Atrophy$0
I01 · FY2015 · VA · contact PI
Molecular Mechanisms of Age-related Muscle Loss$0
I01 · FY2015 · VA · contact PI
Molecular Pathogenesis of Skeletal Muscle Atrophy$285,768
R01 · FY2014 · AR · contact PI
Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy$225,000
R41 · FY2014 · AG · contact PI
Molecular Mechanisms of Age-related Muscle Loss$0
I01 · FY2014 · VA · contact PI
Molecular Pathogenesis of Skeletal Muscle Atrophy$307,800
R01 · FY2013 · AR · contact PI
Development of novel therapies for aging-induced skeletal muscle atrophy.$160,002
R43 · FY2013 · AG
Molecular Mechanisms of Age-related Muscle Loss$0
I01 · FY2013 · VA · contact PI
Molecular Pathogenesis of Skeletal Muscle Atrophy$324,000
R01 · FY2012 · AR · contact PI
Molecular Mechanisms of Age-related Muscle Loss$0
I01 · FY2012 · VA · contact PI
Molecular Mechanisms of Age-related Muscle Loss$0
I01 · FY2012 · VA · contact PI
Molecular Pathogenesis of Skeletal Muscle Atrophy$324,000
R01 · FY2011 · AR · contact PI
Molecular Pathogenesis of Skeletal Muscle Atrophy$337,500
R01 · FY2010 · AR · contact PI